For citations:
Fedyanin M.Yu., Rays A.B., Besova N.S., Obarevich E.S., Gavrilova D.A., Adu-Haidar O.B., Karasev I.A., Kozlov N.A., Tryakin A.А., Stilidi I.S. Efficacy of chemoimmunotherapy in first-line treatment of patients with disseminated gastric cancer depending on PD-L1 expression and clinical benefit according to the ESMO-MCBS and RUSSCO criteria: results of a meta-analysis. Malignant tumours. 2025;15(4):33–46. (In Russ.) https://doi.org/10.18027/2224-5057-2025-061
JATS XML
Email this article 